头条

股票

Ipsen completes acquisition of Kartos Therapeutics

The French biopharmaceutical company said it has finalized the purchase of Kartos Therapeutics to strengthen its oncology pipeline.

Ipsen headquarters in France

更多法国新闻

法国市场解读